<h2>最近的股价表现和业务规模</h2>
<p>雀巢（SWX:NESN）在经历了一段混合回报后重新吸引了投资者的关注，过去一个月股价上涨，但过去 3 年和 5 年股价下跌。</p>
<p>该公司收盘价为 78.80 瑞士法郎，过去一天回报约为 0.2%，过去一周为 2.5%，过去一个月为 4.6%，而过去 3 个月股价下降约 2.6%。</p>
<p>在更长的时间段内，雀巢的总回报年初至今上涨约 3.1%，但过去一年下降约 7%，过去 3 年下降 21.2%，过去 5 年下降 16.7%。</p>
<p>雀巢报告的年收入为 899 亿瑞士法郎，净收入为 90 亿瑞士法郎，基于最新数据，年收入增长 2.4%，净收入增长 8.2%。</p>
<p>该集团涵盖多个领域，包括咖啡、糖果、营养、宠物护理和高端饮品。它在北美、欧洲、亚洲、拉丁美洲和大中华区运营，其中美国是其收入最大的单一市场。</p>
<p>请查看我们对雀巢的最新分析。</p>
<p>最近一个月股价回报 4.6% 与过去一年约 7% 的总股东回报形成对比。这表明近期的势头正在改善，而长期回报仍然疲软。</p>
<p>如果您正在重新评估围绕雀巢这样的大型消费品股票的投资组合，扩大您的观察名单，关注 99 家顶级创始人领导的公司可能会很有帮助。</p>
<p>雀巢的交易价格为 78.80 瑞士法郎，数据表明其相对于一些估值预期存在折扣，并且多年的回报表现较弱，关键问题是这是否是一个买入机会，还是市场已经在定价未来的增长。</p>
<h2>最受欢迎的叙述：低估 10.3%</h2>
<p>与最后收盘价 78.80 瑞士法郎相比，最受关注的叙述指出其公允价值约为 87.87 瑞士法郎，基于其长期观点和 3.94% 的折现率，暗示适度的上行空间。</p>
<blockquote>
<p><em>宠物护理、咖啡和高端科学营养仍然是结构性增长引擎，受到全球宠物拥有率上升、城市化和对科学支持的功能性食品解决方案需求的推动。这些驱动因素，加上类别势头的恢复和进一步高端化的能力，为持续的收入和利润扩张提供了潜力。</em></p>
</blockquote>
<p>阅读完整叙述。</p>
<p>想知道需要什么样的收入组合、利润提升和收益路径来证明这种估值差距吗？该叙述依赖于稳健的增长、更丰富的产品组合和更紧凑的股份数量来支持其长期定价。想知道这些动态因素如何随着时间的推移共同发挥作用。</p>
<p><strong>结果：公允价值为 87.87 瑞士法郎（低估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，仍然存在明显的压力点，包括由于咖啡和可可成本上升以及大中华区需求疲软而带来的利润压力，这可能会挑战这一上行故事。</p>
<p>了解雀巢叙述的主要风险。</p>
<h2>估值的另一种视角</h2>
<p>叙述的公允价值 87.87 瑞士法郎表明雀巢在 78.80 瑞士法郎的交易中有适度的上行空间。然而，从简单的收益角度来看，该股票的市盈率为 22.4 倍，高于欧洲食品行业的 16.6 倍，但略低于其自身的公允比率 24.8 倍。这种与同行的溢价和与公允比率的折扣的组合让您权衡这是在定价质量还是在构建估值风险。</p>
<p>要更仔细地查看收益倍数与同行、行业和公允比率的对比，值得检查详细的估值细分，包括随时间变化的公允比率差距，查看数字对该价格的看法——在我们的估值细分中了解。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8dbe15b8-4f0f-4b69-bfb2-7a35503076db/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTIx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1640" height="650" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8dbe15b8-4f0f-4b69-bfb2-7a35503076db/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTIx"/></p>
<p>截至 2026 年 5 月的 SWX:NESN 市盈率</p>
<h2>下一步</h2>
<p>鉴于本文的情绪感受混合，将其作为提示，自己检查完整数据，并决定您对风险和回报之间的权衡有多舒适。要清晰地看到双方，请查看 3 个关键回报和 1 个重要警告信号。</p>
<h2>寻找更多投资想法？</h2>
<p>如果您只关注一只股票，您可能会错过其他更适合您目标的机会，因此请通过一些有针对性的筛选来扩大范围。</p>
<ul>
<li>通过查看被标记为 479 个股息堡垒的公司来瞄准稳定的收入，看看哪些公司可以增强您投资组合的收入部分。</li>
<li>通过扫描 227 只高质量低估股票，寻找潜在折扣的优质股票，并比较基本面和定价更符合您偏好的企业。</li>
<li>通过查看包含 534 个高质量未被发现的宝藏的筛选器，保持领先，发现较少投资者可能密切关注的稳健企业。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，性质一般。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3>估值复杂，但我们在这里简化它。</h3>
<p>通过我们的详细分析，发现雀巢可能被低估或高估，分析内容包括 <strong>公允价值估计、潜在风险、股息、内部交易及其财务状况。</strong></p>
<p>获取免费分析</p>

雀巢(ADR)

雀巢

<p>雀巢 (SWX:NESN) 的长期回报表现参差不齐，最近一个月股价上涨了 4.6%，但过去一年却下跌了 7%。该股票收盘价为 78.80 瑞士法郎，暗示其可能被低估，公允价值为 87.87 瑞士法郎。尽管在宠物护理和咖啡等领域存在结构性增长，但在大中华区仍面临成本上升和需求问题等挑战。建议投资者在做出决策之前评估风险与收益的平衡</p>

<h2>Recent share performance and business scale</h2>
<div class="lb-trans"><h2>最近的股价表现和业务规模</h2>
</div><p>Nestlé (SWX:NESN) has drawn fresh investor attention after a recent stretch of mixed returns, with the stock up over the past month but down over the past 3 years and past 5 years.</p>
<div class="lb-trans"><p>雀巢（SWX:NESN）在经历了一段混合回报后重新吸引了投资者的关注，过去一个月股价上涨，但过去 3 年和 5 年股价下跌。</p>
</div><p>The company closed at CHF 78.80, with a return of about 0.2% over the past day, 2.5% over the past week and 4.6% over the past month, while the share price declined about 2.6% over the past 3 months.</p>
<div class="lb-trans"><p>该公司收盘价为 78.80 瑞士法郎，过去一天回报约为 0.2%，过去一周为 2.5%，过去一个月为 4.6%，而过去 3 个月股价下降约 2.6%。</p>
</div><p>Over longer periods, Nestlé’s total return is up about 3.1% year to date but lower by about 7% over the past year, 21.2% over the past 3 years and 16.7% over the past 5 years.</p>
<div class="lb-trans"><p>在更长的时间段内，雀巢的总回报年初至今上涨约 3.1%，但过去一年下降约 7%，过去 3 年下降 21.2%，过去 5 年下降 16.7%。</p>
</div><p>Behind the stock, Nestlé reports annual revenue of CHF 89.9b and net income of CHF 9.0b, with annual revenue growth of 2.4% and net income growth of 8.2% based on the latest figures provided.</p>
<div class="lb-trans"><p>雀巢报告的年收入为 899 亿瑞士法郎，净收入为 90 亿瑞士法郎，基于最新数据，年收入增长 2.4%，净收入增长 8.2%。</p>
</div><p>The group spans multiple segments, including coffee, confectionery, nutrition, pet care and premium beverages. It operates across North America, Europe, Asia, Latin America and Greater China, with the United States as its single largest country market by revenue.</p>
<div class="lb-trans"><p>该集团涵盖多个领域，包括咖啡、糖果、营养、宠物护理和高端饮品。它在北美、欧洲、亚洲、拉丁美洲和大中华区运营，其中美国是其收入最大的单一市场。</p>
</div><p>See our latest analysis for Nestlé.</p>
<div class="lb-trans"><p>请查看我们对雀巢的最新分析。</p>
</div><p>The recent 1 month share price return of 4.6% contrasts with a 1 year total shareholder return that is lower by about 7%. This suggests recent momentum is improving, while longer term returns remain weak.</p>
<div class="lb-trans"><p>最近一个月股价回报 4.6% 与过去一年约 7% 的总股东回报形成对比。这表明近期的势头正在改善，而长期回报仍然疲软。</p>
</div><p>If you are reassessing your portfolio around a large consumer staples stock like Nestlé, it can be useful to broaden your watchlist with 99 top founder-led companies</p>
<div class="lb-trans"><p>如果您正在重新评估围绕雀巢这样的大型消费品股票的投资组合，扩大您的观察名单，关注 99 家顶级创始人领导的公司可能会很有帮助。</p>
</div><p>With Nestlé trading at CHF 78.80 and data pointing to both a discount to some valuation estimates and a weaker multi year return profile, the key question is whether this is a buying opportunity or if the market is already pricing in future growth.</p>
<div class="lb-trans"><p>雀巢的交易价格为 78.80 瑞士法郎，数据表明其相对于一些估值预期存在折扣，并且多年的回报表现较弱，关键问题是这是否是一个买入机会，还是市场已经在定价未来的增长。</p>
</div><h2>Most Popular Narrative: 10.3% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：低估 10.3%</h2>
</div><p>Against the last close at CHF 78.80, the most followed narrative points to a fair value of about CHF 87.87, implying a modest upside based on its long term view and discount rate of 3.94%.</p>
<div class="lb-trans"><p>与最后收盘价 78.80 瑞士法郎相比，最受关注的叙述指出其公允价值约为 87.87 瑞士法郎，基于其长期观点和 3.94% 的折现率，暗示适度的上行空间。</p>
</div><blockquote>
<p><em>PetCare, coffee, and premium science-led nutrition remain structural growth engines, underpinned by the global rise in pet ownership, urbanization, and demand for science-backed and functional food solutions. These drivers, combined with recovering category momentum and capacity for further premiumization, offer potential for sustained revenue and margin expansion.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>宠物护理、咖啡和高端科学营养仍然是结构性增长引擎，受到全球宠物拥有率上升、城市化和对科学支持的功能性食品解决方案需求的推动。这些驱动因素，加上类别势头的恢复和进一步高端化的能力，为持续的收入和利润扩张提供了潜力。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Want to see what kind of revenue mix, margin lift and earnings path it takes to justify that valuation gap? The narrative leans on measured growth, richer product mix and a tighter share count to support its long term pricing. Curious how those moving parts are expected to work together over time.</p>
<div class="lb-trans"><p>想知道需要什么样的收入组合、利润提升和收益路径来证明这种估值差距吗？该叙述依赖于稳健的增长、更丰富的产品组合和更紧凑的股份数量来支持其长期定价。想知道这些动态因素如何随着时间的推移共同发挥作用。</p>
</div><p><strong>Result: Fair Value of CHF 87.87 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 87.87 瑞士法郎（低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, there are still clear pressure points, including margin headwinds from higher coffee and cocoa costs and softer demand in Greater China, that could challenge this upside story.</p>
<div class="lb-trans"><p>然而，仍然存在明显的压力点，包括由于咖啡和可可成本上升以及大中华区需求疲软而带来的利润压力，这可能会挑战这一上行故事。</p>
</div><p>Find out about the key risks to this Nestlé narrative.</p>
<div class="lb-trans"><p>了解雀巢叙述的主要风险。</p>
</div><h2>Another lens on valuation</h2>
<div class="lb-trans"><h2>估值的另一种视角</h2>
</div><p>The narrative fair value of CHF 87.87 points to Nestlé trading on modest upside at CHF 78.80. On simple earnings terms though, the stock changes hands at a P/E of 22.4x, higher than the European food sector on 16.6x, yet slightly below its own fair ratio of 24.8x. That mix of premium versus peers and discount versus the fair ratio leaves you weighing whether this is pricing in quality or building in valuation risk.</p>
<div class="lb-trans"><p>叙述的公允价值 87.87 瑞士法郎表明雀巢在 78.80 瑞士法郎的交易中有适度的上行空间。然而，从简单的收益角度来看，该股票的市盈率为 22.4 倍，高于欧洲食品行业的 16.6 倍，但略低于其自身的公允比率 24.8 倍。这种与同行的溢价和与公允比率的折扣的组合让您权衡这是在定价质量还是在构建估值风险。</p>
</div><p>For a closer look at how earnings multiples line up with peers, sector and the fair ratio, it is worth checking the detailed valuation breakdown, including the gap to the fair ratio over time, in See what the numbers say about this price — find out in our valuation breakdown.</p>
<div class="lb-trans"><p>要更仔细地查看收益倍数与同行、行业和公允比率的对比，值得检查详细的估值细分，包括随时间变化的公允比率差距，查看数字对该价格的看法——在我们的估值细分中了解。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8dbe15b8-4f0f-4b69-bfb2-7a35503076db/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTIx" alt="" original-src="https://images.simplywall.st/company/8dbe15b8-4f0f-4b69-bfb2-7a35503076db/chart/pe-multiple-vs-industry?date=2026-05-21"/></p>
<p>SWX:NESN P/E Ratio as at May 2026</p>
<div class="lb-trans"><p>截至 2026 年 5 月的 SWX:NESN 市盈率</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><p>With sentiment in this article feeling mixed, use it as a prompt to check the full data for yourself and decide how comfortable you are with the trade off between risk and reward. To see both sides set out clearly, review the 3 key rewards and 1 important warning sign</p>
<div class="lb-trans"><p>鉴于本文的情绪感受混合，将其作为提示，自己检查完整数据，并决定您对风险和回报之间的权衡有多舒适。要清晰地看到双方，请查看 3 个关键回报和 1 个重要警告信号。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>If you stop with just one stock, you risk missing out on other opportunities that might suit your goals even better, so widen the net with a few targeted screens.</p>
<div class="lb-trans"><p>如果您只关注一只股票，您可能会错过其他更适合您目标的机会，因此请通过一些有针对性的筛选来扩大范围。</p>
</div><ul>
<li>Target resilient income by checking out companies tagged as 479 dividend fortresses and see which ones could strengthen the income side of your portfolio.</li>
<li>Hunt for quality at a potential discount by scanning the 227 high quality undervalued stocks and compare businesses where fundamentals and pricing look more aligned with your preferences.</li>
<li>Stay one step ahead by reviewing the screener containing 534 high quality undiscovered gems and spot solid businesses that fewer investors may be watching closely.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过查看被标记为 479 个股息堡垒的公司来瞄准稳定的收入，看看哪些公司可以增强您投资组合的收入部分。</li>
<li>通过扫描 227 只高质量低估股票，寻找潜在折扣的优质股票，并比较基本面和定价更符合您偏好的企业。</li>
<li>通过查看包含 534 个高质量未被发现的宝藏的筛选器，保持领先，发现较少投资者可能密切关注的稳健企业。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，性质一般。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3>Valuation is complex, but we're here to simplify it.</h3>
<div class="lb-trans"><h3>估值复杂，但我们在这里简化它。</h3>
</div><p>Discover if Nestlé might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p>
<div class="lb-trans"><p>通过我们的详细分析，发现雀巢可能被低估或高估，分析内容包括 <strong>公允价值估计、潜在风险、股息、内部交易及其财务状况。</strong></p>
</div><p>Access Free Analysis</p>
<div class="lb-trans"><p>获取免费分析</p>
</div>

在长期回报表现不一以及近期股价动量的背景下，评估雀巢（SWX:NESN）的估值